Transforming Drug Discovery Into Better Medicines.
Bloom D³ is a biotechnology company advancing therapeutics in cardiometabolic disease, oncology, and infectious disease — built in Africa, built for the world.
Discovery science, built for global impact.
Bloom D³ — Bloom Drug, Discovery and Development — is an African biotechnology company developing next-generation therapeutics for the diseases that matter most to global health.
We combine rigorous scientific standards with a deep understanding of the markets and populations too often left out of drug development, building medicines designed to move from discovery to patients with speed and integrity.
Three areas. One standard of rigor.
Cardiometabolic Disease
Developing therapeutics for the conditions driving the fastest-growing disease burden worldwide.
Oncology
Advancing targeted approaches to cancers with high unmet need and limited treatment access.
Infectious Disease
Building solutions for diseases that disproportionately affect underserved populations.
From bench to bedside.
Bloom D³ is building a portfolio of therapeutics designed to move through development with speed and scientific rigor, at every stage.
Discovery
Target identification and early candidate research across our three focus areas.
Preclinical
Rigorous testing to establish safety and efficacy ahead of clinical development.
Clinical
Trial design and execution built to global regulatory standards.
Partnership
Collaboration pathways to bring therapeutics to the patients who need them.
Science rooted in Africa. Built for the world.
Africa carries a significant share of the global disease burden yet remains underrepresented in drug discovery. Bloom D³ was built to close that gap — combining world-class scientific standards with deep regional insight to develop medicines that serve global markets, starting with the populations too often overlooked.
Collaboration built on shared standards.
We work with pharmaceutical companies, research institutions, investors, and global health organizations who share our commitment to advancing medicine where it’s needed most.
Let’s talk.
Whether you’re a potential partner, investor, researcher, or candidate, we’d like to hear from you.